Frédéric Pâques
Chief Executive Officer chez Standing Ovation SAS
Profil
Frédéric Pâques is the founder and currently holds the position of Chairman & Chief Executive Officer at Standing Ovation SAS, which is founded in 2020.
He previously held the position of Director at Takara Bio Europe AB.
From 2001 to 2012, he was the Chief Scientific Officer at Cellectis SA. From 2013 to 2020, he was the Chief Technology Officer at Global Bioenergies SA. Dr. Pâques received his doctorate degree from Université Paris 1 Panthéon-Sorbonne in 1994 and his undergraduate degree from École Normale Supérieure.
Postes actifs de Frédéric Pâques
| Sociétés | Poste | Début |
|---|---|---|
Standing Ovation SAS
 Standing Ovation SAS Food: Meat/Fish/DairyConsumer Non-Durables Part of UNIBEL SA, Standing Ovation SAS is a French company that specializes in animal-free dairy cheese. The private company is based in Paris, France. Standing Ovation is focused on providing new solutions to environmental and ethical challenges. The company was founded in 2020 by Romain Chayot, Frédéric Pâques. Frédéric Pâques has been the CEO since 2020. Standing Ovation was acquired by Bel SA on November 15, 2022. | Chief Executive Officer | 24/06/2020 |
Anciens postes connus de Frédéric Pâques
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBAL BIOENERGIES | Chief Operating Officer | 01/06/2020 |
| CELLECTIS S.A. | Chief Tech/Sci/R&D Officer | 30/01/2012 |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Director/Board Member | - |
Formation de Frédéric Pâques
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
| École Normale Supérieure | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| GLOBAL BIOENERGIES | Process Industries |
| Entreprise privées | 2 |
|---|---|
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |
Standing Ovation SAS
Standing Ovation SAS Food: Meat/Fish/DairyConsumer Non-Durables Part of UNIBEL SA, Standing Ovation SAS is a French company that specializes in animal-free dairy cheese. The private company is based in Paris, France. Standing Ovation is focused on providing new solutions to environmental and ethical challenges. The company was founded in 2020 by Romain Chayot, Frédéric Pâques. Frédéric Pâques has been the CEO since 2020. Standing Ovation was acquired by Bel SA on November 15, 2022. | Consumer Non-Durables |
